162 related articles for article (PubMed ID: 30096811)
1. Real-World Implications of Nonbiological Factors with Staging, Prognosis and Clinical Management in Colon Cancer.
Liu Q; Luo D; Cai S; Li Q; Li X
Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30096811
[No Abstract] [Full Text] [Related]
2. Real-world clinical significance of nonbiological factors with staging, prognosis and clinical management in rectal cancer.
Gao TM; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Eur J Surg Oncol; 2021 May; 47(5):990-998. PubMed ID: 33046280
[TBL] [Abstract][Full Text] [Related]
3. Real-world implications of nonbiological factors with staging, clinical management, and prognostic prediction in pancreatic ductal adenocarcinoma.
Wang C; Chen H; Deng X; Xu W; Shen B
Cancer Med; 2023 Jan; 12(1):651-662. PubMed ID: 35661437
[TBL] [Abstract][Full Text] [Related]
4. Incorporating non-biological factors into the TNM staging system for better prognostication and decision-making in testicular cancer.
Huang Y; Sheng H; Zhang J; Liu Q; Ye D; Shi G
World J Urol; 2019 Oct; 37(10):2165-2173. PubMed ID: 30554272
[TBL] [Abstract][Full Text] [Related]
5. Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.
Liu Q; Ma Y; Luo D; Cai S; Li Q; Li X
Int J Colorectal Dis; 2018 Aug; 33(8):1107-1114. PubMed ID: 29770845
[TBL] [Abstract][Full Text] [Related]
6. Implications of Pretreatment Serum Carcinoembryonic Antigen Levels and Perineural Invasion with Staging, Prognosis, and Management in Stage I-III Colon Cancer after Surgery: A Retrospective Cohort Study in the SEER Database.
Zhang Q; Wang L; Sun R; Gao J; Liu T
Ann Ital Chir; 2024; 95(2):144-154. PubMed ID: 38684496
[TBL] [Abstract][Full Text] [Related]
7. P-TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management.
Liu Q; Luo D; Cai S; Li Q; Li X
Cancer Manag Res; 2018; 10():2303-2314. PubMed ID: 30104899
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Nonbiological Factors With Colorectal Cancer Patients Younger Than 45 Years.
Liu Q; Zhang R; Li Q; Li X
Front Oncol; 2021; 11():677198. PubMed ID: 34307145
[TBL] [Abstract][Full Text] [Related]
9. Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study.
Liu Q; Lian P; Luo D; Cai S; Li Q; Li X
Onco Targets Ther; 2018; 11():5827-5834. PubMed ID: 30271165
[TBL] [Abstract][Full Text] [Related]
10. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
[TBL] [Abstract][Full Text] [Related]
11. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.
Abdel-Rahman O
Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248
[TBL] [Abstract][Full Text] [Related]
12. The new 'coN' staging system combining lymph node metastasis and tumour deposit provides a more accurate prognosis for TNM stage III colon cancer.
Wang X; Cheng W; Dou X; Tan F; Yan S; Zhou Z; Li Y; Xu B; Liu C; Ge H; Tian M; Liu F; Li L; Zhang S; Li Q; Pei H; Pei Q
Cancer Med; 2023 Feb; 12(3):2538-2550. PubMed ID: 35912894
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
14. Impact of Socioeconomic Factors on Prognosis and Clinical Management in Patients with Hepatocellular Carcinoma.
Su BB; Zhou BH; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Turk J Gastroenterol; 2021 Aug; 32(8):667-677. PubMed ID: 34528880
[TBL] [Abstract][Full Text] [Related]
15. Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.
Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
[No Abstract] [Full Text] [Related]
16. Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System.
Liu Z; Chen S; Huang Y; Hu D; Wang M; Wei W; Zhang C; Zeng W; Guo L
Front Oncol; 2019; 9():1093. PubMed ID: 31681617
[No Abstract] [Full Text] [Related]
17. New proposed tumor-node-metastasis staging system for medullary thyroid carcinoma based on the Surveillance, Epidemiology, and End Results database.
Wang M; Hu D; Zeng W; Chen S; Huang Y; Zhou L; Zhou W; Wei W; Zhang C; Liu Z; Guo L
Am J Transl Res; 2020; 12(6):2703-2710. PubMed ID: 32655802
[TBL] [Abstract][Full Text] [Related]
18. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
19. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Socioeconomic Status on Staging, Prognosis in Hepatocellular Carcinoma.
Zhou Y; Zhang W; Ma J; Zhang Z; Yang M; Luo J; Yan Z
Int J Gen Med; 2022; 15():1459-1469. PubMed ID: 35210820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
